Business

Novo Nordisk CEO on Hims Suit, Wegovy Demand and Pricing

Published

on



Novo Nordisk says more than 246000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version